Travel grant 2024 Switzerland, Swiss Nordic Bio 2024 on March 7

Purpose and goal:

The objective for the conference was to meet and engage with potential Swiss investors and pharma companies that we had not yet had any dialogue with.

We had a range of productive first-hand meetings and we consider it a success that we got in touch with a segment of investors we normally don´t have access to or meet. Thus the goals prior to the conference have been met. Expected results and effects:

A range of productive first-hand meetings with potential prospective investors we had not previously met. No pharma companies of interest were participating on the day. Approach and implementation:

We had a 10 minute presentation followed by lunch mingle and 1-to-1 meetings with prospective investors. The meetings were all productive and have opened new dialogues for the company.